Shareholders Filed a Lawsuit Against Viatris for Hiding FDA Enforcement Risks
Court: W.D. Pennsylvania
Case: 2:25-cv-00466
On April 4, 2025, 
VTRS shareholders have filed a class action against Viatris, accusing it of hiding the seriousness of an FDA warning at its India-based Indore manufacturing plant.
What is this lawsuit about?
On February 27, 2025, Viatris revealed that an FDA import alert would slash its 2025 revenue by $500 million and reduce operating income by $385 million. Following this, VTRS dropped 15.2% in one day.
What can you do to recover your losses now?
We’re keeping track of all updates and will notify VTRS investors about potential recovery.
More than 600 companies are currently facing securities class action lawsuits, and over 100 are already paying settlements. Connect your brokerage account to automatically check which ones you may have missed.